Find insight on Bayer, Malaysia’s glove exporters and more in the latest Market Talks covering the Health Care sector.

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

AstraZeneca's Breztri Aerosphere in India is made using a new type of gas (called a next-generation propellant) that does not ...

Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r ...

Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering if that's been reciprocated. The post 21 analysts advised buy AstraZeneca ...

DRUG giants were put on notice by Donald Trump yesterday that he would be slashing prices for medicines in the US to the cheapest available. The move is another blow for Britain’s drug giants ...

Net loss from continuing operations for the first quarter of 2025 was $16.8 million, or $0.16 net loss per basic and diluted share, compared to a net loss of $49.0 million, or $0.49 net loss per basic ...

A panel at OCT Europe touched upon where the European clinical trial industry is headed and the impact of technology and ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

Shares of the international biopharmaceutical company AstraZeneca Plc fell by 5.8% during trading on Monday, resulting in the ...

Trump claimed his order will "almost immediately" reduce prescription drug and pharmaceutical prices by 30% to 80%. On average, Americans pay about three times more for prescription drugs than ...